Rights and permissions
About this article
Cite this article
Fondaparinux has the edge over enoxaparin in ACS. Inpharma Wkly. 1505, 11–12 (2005). https://doi.org/10.2165/00128413-200515050-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200515050-00026